Introduction: NECs of colon origin are orphan and highly aggressive neoplasms with limited molecular knowledge.
Aim(s): To describe the DNA genomic and epigenomic aberrations of colon NECs, generate a patient-derived xenograft (PDX) model to perform translational experiments and translate the results to the clinical setting.
Materials and methods: DNA alterations were defined by VHIOCard (genotyping up to 700 mutations in 70 cancer-related genes). Microsatellite instability (MSI) was analyzed by immunohistochemistry (IHC) and polymerase chain reaction (PCR). Epigenetic changes were studied by DNA methylation analyses using microarray strategy (Illumina®) and compared with colon adenocarcinomas (ADK). We created a BRAFV600E mutated PDX of colon NEC that was treated with cisplatin-etoposide, cetuximab, and the BRAF inhibitor LGX818.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Basic Science - Genetics, epigenetics, miRNAs, Omics
Presenting Author: Dr Jaume Capdevila
, Mancuso F
, Landolfi S
, Martinez-Cardus A
, Barriuso J
, Lopez C
, Grande E
, Miguel C
, Garcia-Carbonero R
, Hernando J
, Vivancos A
, Garcia-Palmer H
To read results and conclusion, please login ...
Further abstracts you may be interested in